Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Operational Review
RMD logo

ResMed Revenue Climbs 10% to $1.282B, Net Income Surges 65%

RMD10-QFiling Date: 1/31/2025
ResMed Inc.
Description

What this story covers

ResMed's Q2 FY2025 10-Q reveals 10 percent revenue growth to 1.282 billion dollars, driven by sleep health devices and software. Gross margins improved to 58.6 percent, operating income up 52 percent to 417 million dollars, net income 65 percent higher at 345 million dollars. Strong liquidity, low debt, and 2030 strategy focus on connected care amid rising sleep disorder demand.

Story snapshot

CompanyResMed Inc.
TickerRMD
VariantStandard detailed
Duration12:44
Filing type10-Q
PeriodQ2 2025
IndustryHealthcare & Pharmaceuticals
Accession0000943819-25-000004

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in